Cognition Therapeutics, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $51.3M | $54.7M |
| FY2022 | — | $40.2M | $41.6M |
| FY2023 | — | $24.5M | $29.9M |
| FY2024 | — | $18.8M | $25.0M |
| FY2025 | — | $34.3M | $36.8M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $51.3M | $54.7M |
| FY2022 | — | $40.2M | $41.6M |
| FY2023 | — | $24.5M | $29.9M |
| FY2024 | — | $18.8M | $25.0M |
| FY2025 | — | $34.3M | $36.8M |